Shalby Limited (SHALBY) fundamentals
Shalby Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as SHALBY (ISIN INE597J01018). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Shalby Limited does
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. Its segments include Healthcare Services segment, which includes the business of setting up and managing hospitals and medical diagnostics services, and Manufacturing segment, which includes the manufacturing of implants. The Company’s divisions include Hospital business, Shalby Orthopedics Centre of Excellence (SOCE) franchise, Homecare, and Implant Business. SOCE offers a comprehensive orthopedic center for all orthopedic-related issues, including joint replacement surgery. The Company offers a range of specialties, which include critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, dental cosmetics and implantology, and ophthalmology. It has approximately 11 multi-specialty hospitals.
Valuation and market data
| Last close | ₹144.84 |
|---|---|
| Market capitalisation | ₹1,555 crore |
| Enterprise value | ₹1,791 crore |
| P/E (TTM) | 44.84 |
| Price to book | 1.55 |
| Price to sales (TTM) | 0.76 |
| Book value per share | ₹93.67 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Fri Dec 15 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,168 crore | ₹61 crore | ₹35 crore | 3.23 |
| Mar 2025 | ₹1,115 crore | ₹56 crore | ₹2 crore | 0.18 |
| Mar 2024 | ₹953 crore | ₹128 crore | ₹84 crore | 7.78 |
| Mar 2023 | ₹827 crore | ₹102 crore | ₹68 crore | 6.31 |
| Mar 2022 | ₹711 crore | ₹79 crore | ₹54 crore | 5.00 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 74.3% |
|---|---|
| Foreign institutions (FII) | 4.5% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.3% |
| Retail and others | 20.9% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.